NCT06007235 - CACIPLIQ20 in Wound Healing in Subjects With Epidermolysis Bullosa | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 29, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions

Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa, Junctional

Interventions

DEVICE

CACIPLIQ20

CACIPLIQ20 contains RGTA heparan sulphate mimetics

DRUG

Placebo

Saline solution in identical spray bottles

Trial Locations (1)

RECRUITING

Hopital Necker - enfants malades, Paris